Saturn V Capital Management LP

Q3 2025 13F Holdings

  • Location
    austin, TX
  • Num holdings

    17

  • Value ($000)

    $455,971

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001964437
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ABIVAX SA

SPONSORED ADS
00370M103
$68.02M
15 %

801,224

A
AMLX

AMYLYX PHARMACEUTICALS INC

COM
03237H101
$62.58M
14 %

4,604,878

---

JAZZ PHARMACEUTICALS PLC

SHS USD
G50871105
$39.62M
9 %

300,610

D
DYN

DYNE THERAPEUTICS INC

COM
26818M108
$33.83M
7 %

2,674,469

C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$29.08M
6 %

2,025,041

P
PCVX

VAXCYTE INC

COM
92243G108
$28.40M
6 %

788,441

C
CELC

CELCUITY INC

COM
15102K100
$23.41M
5 %

473,828

C
CGON

CG ONCOLOGY INC

COM
156944100
$23.36M
5 %

579,895

I
IRON

DISC MEDICINE INC

COM
254604101
$22.53M
5 %

340,897

---

PHARVARIS N V

COM
N69605108
$22.11M
5 %

886,332

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 17